Peroxiredoxins in the central nervous system

Subcellular Biochemistry

Volumn 44, Issue , 2007, Pages 357-374

  Hattori, Fumiyuki ^a   Oikawa, Shinzo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer s disease; Amylotrophic lateral sclerosis; Excitotoxicity; Neurodegeneration; Oxidative stress; Parkinson s disease; Stroke

Indexed keywords

AMINO ACID RECEPTOR STIMULATING AGENT; IBOTENIC ACID; ISOENZYME; NEUROPROTECTIVE AGENT; PEROXIREDOXIN;

ADENOVIRUS; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICALLY INDUCED DISORDER; DEGENERATIVE DISEASE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; OXIDATIVE STRESS; RAT; REVIEW;

ADENOVIRIDAE; ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IBOTENIC ACID; ISOENZYMES; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PEROXIREDOXINS; RATS; TRANSDUCTION, GENETIC;

EID: 38749099103     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4020-6051-9_17     Document Type: Article

References (69)

1. Alexandrova, M., Bochev, P., Markova, V. Bechev, B., Popova, M., Danovska, M., Simeonova, V., 2004, Dynamics of free radical processes in acute ischemic stroke: influence on neurological status and outcome. J. Clin. Neurosci. 11: 501-506.
2. Andoh, T., Chock, P. B., Chiueh, C. C., 2002, The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells. J. Biol. Chem. 277: 9655-9660.
3. Asahina, M., Yamada, T., Yoshiyama, Y., Yodoi, J., 1998, Expression of adult T cell leukemia-derived factor in human brain and peripheral nerve tissues. Dement. Geriatr. Cogn. Disord. 9: 181-185.
4. Bai, J., Nakamura, H., Hattori, I., Tanito, M., Yodoi, J., 2002, Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells. Neurosci. Lett. 321: 81-84.
5. Beal, M. F., 1995, Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38: 357-366.
6. Beal, M. F., Ferrante, R. J., Browne, S. E., Matthews, R. T., Kowall, N. W., Brown, R. H., Jr., 1997, Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42: 644-654.
7. Bellomo, G., Mirabelli, F., Vairetti, M, Iosi, F, Malorni, W., 1990, Cytoskeleton as a target in menadioneinduced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features. J. Cell. Physiol. 143: 118-128.
8. Bryk, R., Griffin, P., Nathan, C., 2000, Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407: 211-215.
9. Chen, W., Ji, J., Ru, B., 2005, Proteomic analysis of corticobasal degeneration: a case study of corticobasal degeneration at the proteome level. J. Neuropsychiatry Clin. Neurosci. 17: 364-371.
10. Chen, W., Ji, J., Xu, X., He, S., Ru, B., 2003, Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins. Int. J. Dev. Neurosc. i 21: 209-216.
11. Demirkaya, S., Topcuoglu, M. A., Aydin, A., Ulas, U. H., Isimer, A. I., 2001, Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur. J. Neurol. 8: 43-51.
12. Dexter, D. T., Holley, A. E., Flitter, W. D., Slater, T. F., Wells, F. R., Daniel, S. E., Lees, A. J., Jenner, P., Marsden, C. D., 1994, Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9: 92-97.
13. Dyrks, T., Dyrks, E., Masters, C. L., Beyreuther, K., 1993, Amyloidogenicity of rodent and human beta A4 sequences. FEBS Lett. 324: 231-236.
14. Eftekharpour, E., Holmgren, A., Juurlink, B H., 2000, Thioredoxin reductase and glutathione synthesis is upregulated by t-butylhydroquinone in cortical astrocytes but not in cortical neurons. Glia 31: 241-248.
15. Ferrante, R. J., Browne, S. E., Shinobu, L. A., Bowling, A. C., Baik, M. J., MacGarvey, U., Kowall, N. W., Brown, R. H., Jr., Beal, M. F., 1997, Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69: 2064-2074.
16. Floyd, R. A, Hensley, K., 2002, Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23: 795-807.
17. Hattori, F., Murayama, N., Noshita, T., Oikawa, S., 2003, Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J. Neurochem. 86: 860-868.
18. Hattori, I., Takagi, Y., Nozaki, K., Kondo, N., Bai, J., Nakamura, H., Hashimoto, N., Yodoi, J., 2002, Hypoxia-ischemia induces thioredoxin expression and nitrotyrosine formation in new-born rat brain. Redox Rep. 7: 256-259.
19. Ichimiya, S., Davis, J. G., O'Rourke, D. M., Katsumata, M., Greene, M. I., 1997, Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury. DNA Cell Biol. 16: 311-321.
20. Jin, M. H., Lee, Y. H., Kim, J. M., Sun, H. N., Moon, E. Y., Shong, M. H., Kim, S. U., Lee, S. H., Lee, T. H., Yu, D. Y., Lee, D. S., 2005, Characterization of neural cell types expressing peroxiredoxins in mouse brain. Neurosci. Lett. 381: 252-257.
21. Kikuchi, S., Shinpo, K., Takeuchi, M., Tsuji, S., Yabe, I., Niino, M., Tashiro, K., 2002, Effect of geranylgeranylaceton on cellular damage induced by proteasome inhibition in cultured spinal neurons. J. Neurosci. Res. 69: 373-381.
22. Kim, S. H., Fountoulakis, M., Cairns, N., Lubec, G., 2001, Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J. Neural. Transm. Suppl (61): 223-235.
23. Kopacek, J., Sakaguchi, S., Shigematsu, K., Nishida, N., Atarashi, R., Nakaoke, R., Moriuchi, R., Niwa, M., Katamine, S., 2000, Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease. J. Virol. 74: 411-417.
24. Krapfenbauer, K., Engidawork, E., Cairns, N., Fountoulakis, M., Lubec, G., 2003, Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 967: 152-160.
25. Krapfenbauer, K., Yoo, B. C., 2002, Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt-Jacob disease. Electrophoresis 23: 2541-2547.
26. Lee, J. M., Shih, A. Y., Murphy, T. H., Johnson, J. A., 2003, NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J. Biol. Chem. 278: 37948-37956.
27. Lippoldt, A., Padilla, C. A., Gerst, H., Andbjer, B., Richter, E., Holmgren, A., Fuxe, K., 1995, Localization of thioredoxin in the rat brain and functional implications. J. Neurosci. 15: 6747-6756.
28. Liu, H., Uno, M., Kitazato, K. T., Suzue, A., Manabe, S., Yamasaki, H., Shono, M., Nagahiro, S., et al., 2004, Peripheral oxidative biomarkers constitute a valuable indicator of the severity of oxidative brain damage in acute cerebral infarction. Brain Res. 1025: 43-50.
29. Lovell, M. A., Ehmann, W. D., Butler, S. M., Markesbery, W. R., 1995, Elevated thiobarbituric acidreactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45: 1594-1601.
30. Lovell, M. A., Xie, C., Gabbita, S. P., Markesbery, W. R., 2000, Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic. Biol. Med. 28: 418-427.
31. Mansur, K., Iwahashi, Y., Kiryu-Seo, S. Su., Q. Namikawa, K., Yodoi, J., Kiyama, H., 1998, Up-regulation of thioredoxin expression in motor neurons after nerve injury. Brain Res. Mol. Brain Res. 62: 86-91.
32. McIntosh, L. J., Trush, M. A., Troncoso, J. C., 1997, Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes. Free Radic. Biol. Med. 23: 183-190.
33. Mecocci, P., MacGarvey, U., Beal, M. F., 1994, Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36: 747-751.
34. Mitsui, A., Hamuro, J., Nakamura, H., Kondo, N., Hirabayashi, Y., Ishizaki-Koizumi, S., Hirakawa, T., Inoue, T., Yodoi, J., 2002, Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid. Redox Signal. 4: 693-696.
35. Mitsui, A., Hirakawa, T., Yodoi, J., 1992, Reactive oxygen-reducing and protein-refolding activities of adult T cell leukemia-derived factor/human thioredoxin. Biochem. Biophys. Res. Commun. 186: 1220-1226.
36. Morimoto, T., Globus, M. Y., Busto, R., Martinez, E., Ginsberg, M. D., 1996, Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 16: 92-99.
37. Nagayama, T., Lan, J., Henshall, D. C., Chen, D., O'Horo, C., Simon, R. P., Chen, J., 2000, Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J. Neurochem. 75: 1716-1728.
38. Nakaso, K., Kitayama, M., Ishii, T., Bannai, S., Yanagawa, T., Kimura, K., Nakashima, K., Ohama, E., Yamada, K., 1999, Effects of kainate-mediated excitotoxicity on the expression of rat counterparts of A170 and MSP23 stress proteins in the brain. Brain Res. Mol. Brain Res. 69: 155-163.
39. Nakaso, K., Kitayama, M., Mizuta, E., Fukuda, H., Ishii, T., Nakashima, K., Yamada, K., 2000, Coinduction of heme oxygenase-1 and peroxiredoxin I in astrocytes and microglia around hemorrhagic region in the rat brain. Neurosci. Lett. 293: 49-52.
40. Nakaso, K., Yano, H., Fukuhara, Y., Takeshima, T., Wada-Isoe K., Nakashima K., 2003, PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett. 546: 181-184.
41. Nordberg, J., Arner, E. S., 2001, Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31: 1287-1312.
42. Patenaude, A., Murthy, M. R., Mirault, M. E., 2005, Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell Mol. Life Sci. 62: 1063-1080.
43. Piantadosi, C. A., Zhang J., 1996, Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 27: 327-331; discussion 332.
44. Plaisant, F., Clippe, A., Van der Stricht, D., Knoops, B., Gressens, P.,. 2003, Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. Free Radic. Biol. Med. 3: 862-872.
45. Powis, G., Montfort W. R., 2001, Properties and biological activities of thioredoxins. Ann. Rev. Pharmacol. Toxicol. 41: 261-295.
46. Powis, G., Mustacich, D., Coon, A., 2000, The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29: 312-322.
47. Rego, A. C., Monteiro, N. M., Silva, A. P., Gil, J., Malva, J. O., Oliveira, C. R., 2003, Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non-desensitizing AMPA receptors in hippocampal cultures. J. Neurochem. 86: 792-804.
48. Requena, J. R., Levine, R. L., 2001, Thioredoxin converts the Syrian hamster (29-231) recombinant prion protein to an insoluble form. Free Radic. Biol. Med. 30: 141-147.
49. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H. X., 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
50. Rozell, B., Hansson, H. A., Luthman, M., Holmgren, A., 1985, Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur. J. Cell Biol. 38: 79-86.
51. Rybnikova, E., Damdimopoulos, A. E., Gustafsson, J. A., Spyrou, G., Pelto-Huikko, M., 2000, Expression of novel antioxidant thioredoxin-2 in the rat brain. Eur. J. Neurosci. 12: 1669-1678.
52. Sakamoto, A., Ohnishi, S. T., Ohnishi, T., Ogawa, R., 1991, Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain. Brain Res. 554: 186-192.
53. Sarafian, T. A., Verity, M. A., Vinters, H. V., Shih, C. C., Shi, L., Ji, X. D., Dong, L., Shau, H., 1999. Differential expression of peroxiredoxin subtypes in human brain cell types. J. Neurosci. Res. 56: 206-212.
54. Seo, M. S., Kang, S. W., Kim, K., Baines, I. C., Lee, T. H., Rhee, S. G., 2000, Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biol. Chem. 275: 20346-20354.
55. Stemme, S., Hansson, H. A., Holmgren, A., Rozell, B., 1985, Axoplasmic transport of thioredoxin and thioredoxin reductase in rat sciatic nerve. Brain Res. 359: 140-146.
56. Su, J. H., Deng, G., Cotman, C. W., 1997, Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Res. 774: 193-199.
57. Takagi, Y., Hattori, I., Nozaki, K., Mitsui, A., Ishikawa, M., Hashimoto, N., Yodoi, J., 2000, Excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice. J. Cereb. Blood Flow Metab. 20: 829-833.
58. Takagi, Y., Horikawa, F., Nozaki, K., Sugino, T., Hashimoto, N., Yodoi, J., 1998, Expression and distribution of redox regulatory protein, thioredoxin during transient focal brain ischemia in the rat. Neurosci. Lett. 251: 25-28.
59. Takagi, Y., Mitsui, A., Nishiyama, A., Nozaki, K., Sono, H., Gon, Y., Hashimoto, N., Yodoi, J., 1999, Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc. Natl. Acad. Sci. USA 96: 4131-4136.
60. Takagi, Y., Tokime, T., Nozaki, K., Gon, Y., Kikuchi, H., Yodoi, J., 1998, Redox control of neuronal damage during brain ischemia after middle cerebral artery occlusion in the rat: immunohistochemical and hybridization studies of thioredoxin. J. Cereb. Blood Flow Metab. 18: 206-214.
61. Tomimoto, H., Akiguchi, I., Wakita, H., Kimura, J., Hori, K., Yodoi, J., 1993, Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia. Brain Res. 625: 1-8.
62. Troncoso, J. C., Costello, A., Watson, A. L., Jr., Johnson, G. V., 1993, In vitro polymerization of oxidized tau into filaments. Brain Res. 613: 313-316.
63. Watabe, S., Hiroi, T., Yamamoto, Y., Fujioka, Y., Hasegawa, H., Yago, N., Takahashi, S. Y., 1997, SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur. J. Biochem. 249: 52-60.
64. White, B. C., Daya, A. DeGracia, D. J., O'Neil, B. J., Skjaerlund, J. M., Trumble, S., Krause, G. S., Rafols, J. A., 1993, Fluorescent histochemical localization of lipid peroxidation during brain reperfusion following cardiac arrest. Acta Neuropathol. (Berl.) 86: 1-9.
65. Wood, Z. A., Schroder, E., Harris, J. R., Poole, L. B., 2003, Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28: 32-40.
66. Yamagata, K., Tagami, M., Ikeda, K. Yamori, Y. Nara, Y., 2000, Altered gene expressions during hypoxia and reoxygenation in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Neurosci. Lett. 284: 131-134.
67. Yang, K. S., Kang, S. W., Woo, H. A,. Hwang, S. C., Chae, H. Z., Kim, K., Rhee, S. G., 2002, Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J. Biol. Chem. 277: 38029-38036.
68. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., Mizuno, Y., 1996, Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93: 2696-2701.
69. Zhou, Y., Zhang, W., Easton, R., Ray, J. W,. Lampe, P,. Jiang, Z., Brunkan, A. L., Goate, A,. Johnson, E M., Wu, J. Y., 2002, Presenilin-1 protects against neuronal apoptosis caused by its interacting protein PAG. Neurobiol. Dis. 9: 126-38.